2022
DOI: 10.1007/s12410-022-09565-x
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Imaging on COVID-19 Pandemic Era: the Stand, The Lost, and Found

Abstract: Purpose of Review The present review will outline the main effects of COVID-19 pandemic on cardiovascular pathologies, focusing on the role of modern non-invasive cardiac imaging techniques in this setting. Recent Findings Multimodality cardiac imaging seems particularly suited for the in-depth characterization of patients with COVID-19, allowing the assessment of the variegated impact of the disease on the different aspects of myocardial perfusion, structure, and funct… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…However, unlike in RoW, where cardiac CT had largely recovered by April 2021, coronary CTA and CAC were still used 18 % and 33 % less frequently than in March 2019, compared to a 5 % increase and 0 % change in RoW (p = 0.003 and p = 0.01). This reflects lasting reductions even in imaging modalities that were generally considered to pose less of a contagion risk between patients and testing staff, [25] and that were not vulnerable to disruptions in radiopharmaceutical supply chains, [26] as with SPECT and PET.…”
Section: Discussionmentioning
confidence: 99%
“…However, unlike in RoW, where cardiac CT had largely recovered by April 2021, coronary CTA and CAC were still used 18 % and 33 % less frequently than in March 2019, compared to a 5 % increase and 0 % change in RoW (p = 0.003 and p = 0.01). This reflects lasting reductions even in imaging modalities that were generally considered to pose less of a contagion risk between patients and testing staff, [25] and that were not vulnerable to disruptions in radiopharmaceutical supply chains, [26] as with SPECT and PET.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, CMR is also essential for differentiating between myocarditis and other possible cardiac manifestations of COVID-19, namely ischemic coronary disease and Takotsubo cardiomyopathy. Here, the presence and pattern of late gadolinium enhancement is essential, along with diffuse myocardial involvement such as edema and fibrosis [ 52 ].…”
Section: Discussionmentioning
confidence: 99%